Purpose of Study: To investigate the clinical manifestation of the ethambutol toxic optic neuropathy Patients and Methods: The ocular toxicity of ethambutol was evaluated in patients taking ATT. This study was carried out at the Department of Pulmonary Medicine and Eye Unit 1, Services Hospital Lahore from Jan 1999 to March 2003. 49 patients were recruited who presented with ocular symptoms. After systemic, ocular and drug history, patients underwent complete ocular examination including visual acuity, color vision, slit lamp examination and fundus examination. Results: Mean age at presentation was 44.6 years with a range between 11 years and 80 years. 8 patients had Diabetes Mellitus and 5 patients had hypertension. Deterioration of vision was noted in 63% of patients who took ATT for more than 6 months in comparison to 22% who took ATT for less than 6 months. Color vision was defective in 76`% of eyes and 26(27%) eyes had defective color vision in spite of having visual acuity of 6/9 or 6/6. Dilated fundus examination revealed normal optic disc in 66(67%) eyes, disc pallor in 27(28%) eyes and 4(4%,) eyes had swollen hyperemic disc. Conclusion: Patients must have baseline ocular examination with special emphasis on visual acuity, color vision, visual field and fundus examination. Patients must have baseline ocular examination before starting ATT containing ethambutol. Evaluation of color vision is more sensitive indicator of optic neuropathy than is the visual acuity and must be evaluated periodically even if the visual acuity in normal.